NeuroDerm Priced, Nasdaq: NDRM

Developing a liquid formulation of levodopa for Parkinson's disease.

Industry: Health Care

Latest Trade: $25.85 -0.15 (-0.6%)

First Day Return: -8.5%

Return from IPO: +160.0%

Industry: Health Care

Developing a liquid formulation of levodopa for Parkinson's disease.
more less
IPO News for NeuroDerm
more
IPO Data
IPO File Date 09/15/2014
Offer Price $10.00
Price Range $13.00 - $16.00
Offer Shares (mm) 4.5
Deal Size ($mm) $45
IPO Data
IPO Date 11/13/2014
Offer Price $10.00
Price Range $13.00 - $16.00
Offer Shares (mm) 4.5
Deal Size ($mm) $45
Underwriters
more
Company Data
Headquarters Rehovot, Israel
Founded 2003
Employees 21
Website www.neuroderm.com